05 September 2016

Pharmacy Brief - September 2016

Welcome to the September edition of our Pharmacy Brief. This edition includes:

We hope you will find the brief useful and will enjoy reading it.

If you have any queries about it, please get in touch with David Reissner, or your usual contact.

To read further, please click here.

We advised Kreos Capital and Silicon Valley Bank on the refinancing of £20 million growth capital investment to Mereo BioPharma Group

Charles Russell Speechlys advises Kreos Capital V Ltd on additional growth capital investment of €20 million in Kiadis Pharma NV

Charles Russell Speechlys have advised Kreos Capital on its additional growth capital facility of €20 million in Cellnovo Limited

There are things pharmacy owners can do which can help the due diligence process to go smoothly and minimise delays.

Insights